This page may contain affiliate links. At no additional cost to you, I will earn a commission if you purchase a product through the links on this page.
Yesterday, the FDA approved a new drug called Aimovig. It the first medication designed specifically to prevent migraines. Until now, the only preventative treatments were medications that are actually for something else, mostly High Blood Pressure and Epilepsy. A lot of people are not helped with these medications and are left with few options…I am in this category.
According to Migraine.com, Aimovig is a “…calcitonin-gene-related peptide (CGRP) blocker. CGRP is a newly identified protein that acts like a neurotransmitter (a chemical messenger) throughout the brain and body. It is a monoclonal antibody that targets and neutralizes the CGRP receptors. By not allowing CGRP to connect with its receptors it helps stop migraine…”.
This targeted treatment is a tremendous advancement in the treatment of migraine and it will change the lives of many Chronic Migraine sufferers. But this treatment will come with a hefty price tag attached (although it is lower than the originally expected). At $6900 a year ($575 per monthly injection), will this medication be a realistic option for the people that need it most?
It is still undetermined if insurance companies will cover the treatment. As with most new treatments, the insurance companies with probably make the Doctors jump through many hoops before they approve the treatment. It will be interesting to see if they will require patients to try medications that are not even FDA approved for the treatment of Migraine before they will authorize this groundbreaking medication.
Even though the price is high, this treatment is a shining glimmer of hope for thousands of Migraine sufferers. It is indeed a step toward a more concise treatment plan for Migraine patients.